Mye wife has breast cancer with bone mets. Her oncologist will put her on a
clinical trial. All we know is an AMGEN trial, we didn't know any specifics
yet. I was on AMGEN site, and saw two trials one is for AMG 162 and the
other one is for AMG 706 plus...
Anyone has any knowledge about these two treatments?
The other question that I have is how I can solve the following delema. The
AMG 162 trail is a randoized, double-blind, placebo-Controlled Study. We
certainly don't want to take placebo, at the same time we want to
particapate in the study. Anyway to get around that?
thanks
Tim Jackson - 05 Mar 2005 11:01 GMT
> Mye wife has breast cancer with bone mets. Her oncologist will put her on a
> clinical trial. All we know is an AMGEN trial, we didn't know any specifics
[quoted text clipped - 9 lines]
>
> thanks
The AMG706 is a chemotherapy trial for mets patients for whom cisplatin
is indicated. This would not generally be the case for breast cancer
patients, bc is not an indicating condition on the prescribing sheet,
and I think it would only be considered if all other chemotherapy
options had been tried and failed. It has terrible side effects. It is
generally indicated for testicular and ovarian cancers.
There are two trials around AMG162. This is a bone-strengthening drug
being proposed as an alternative to bisphosphonates such as Zometa.
The first of these is the double-blind study of AMG162 versus placebo
you mention. This is for non-mets patients on aromatase inhibitors,
looking at use of the drug to combat osteoporosis. So as a mets patient
she is not qualified for this trial either
The other is "AMG 162 in Biphosphonate Naive Metastatic Breast Cancer",
for which she would appear to be eligible. The drug is used here to
reduce the symptoms of bone mets (pain or fracture). This is a
dose-finding study and does not involve placebo. Opting in or out is
unlikely to have any effect on the progression of cancer, this trial is
about improving symptom control.

Signature
Tim Jackson
-Who needs to pay Microsoft? Free Open Source Software-
www.mozilla.org FIREFOX Web Browser, THUNDERBIRD Email/News
www.openoffice.org Office Suite
Ann Barnes - 28 Mar 2005 00:13 GMT
Tim, as a user of Femara, just recently started on Fosamax to inhibit
osteoporosis for which I have only preliminary symptoms, would I potentially
be eligible for the AMG162 study aforementioned?
If so, where on the 'net is info on available studies, qualifying
factors,location, etc...
Ann in PA
Tim Jackson - 29 Mar 2005 19:55 GMT
> Tim, as a user of Femara, just recently started on Fosamax to inhibit
> osteoporosis for which I have only preliminary symptoms, would I potentially
[quoted text clipped - 4 lines]
>
> Ann in PA
This was at
www.amgentrials.com/patients/trials/20040113.htm?catname=cancer&subname=cancer_b
reast&al=No
which you can also get to by going to www.amgen.com and following the
links re. clinical trials and breast cancer.
You can also find trials in the US, including this one, through
www.clinicaltrials.gov

Signature
Tim Jackson
-Who needs to pay Microsoft? Free Open Source Software-
www.mozilla.org FIREFOX Web Browser, THUNDERBIRD Email/News
www.openoffice.org Office Suite
Chris - 11 Mar 2005 03:12 GMT
In a research study, you have to be randomly assigned and blinded to the
drug as the participant for the overall research to be of the
appropriate quality to learn about the treatment through clinical trial.
From the researchers point of view, hopefully they will help you, but
more importantly (for them) they will definitely help a lot of people in
the long run. Most companies have a compassionate use option when you
have reached the end of your treatment rope, as it were. I would expect
that with recent pharmaceutical bad press (ex, Tsybari) drug companies
would be even more cautious about allowing someone to take a non-FDA
approved protocol off of a research study.
So, learn as much as you can about what the particular study is and what
it will get you before deciding. I am sure that a quick call to your
oncologist will get you the protocol number. Also, I am sure that there
is a research coordinator at the research site who can answer your
questions. I have spoken to research coordinators in the past and they
have been very informative. It is in their best interest to have you and
your wife as informed as humanly possible before deciding to be in their
study.
Good luck,
Chris
> Mye wife has breast cancer with bone mets. Her oncologist will put her on a
> clinical trial. All we know is an AMGEN trial, we didn't know any specifics
[quoted text clipped - 9 lines]
>
> thanks